Efficacy of ibrutinib in a patient with transformed lymphoplasmacytic lymphoma and central nervous system involvement

Leuk Lymphoma. 2018 May;59(5):1256-1259. doi: 10.1080/10428194.2017.1369074. Epub 2017 Aug 29.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adenine / analogs & derivatives
  • Cell Transformation, Neoplastic / drug effects*
  • Cell Transformation, Neoplastic / pathology
  • Central Nervous System Diseases / complications
  • Central Nervous System Diseases / drug therapy*
  • Central Nervous System Diseases / pathology
  • Female
  • Humans
  • Middle Aged
  • Piperidines
  • Prognosis
  • Pyrazoles / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Waldenstrom Macroglobulinemia / complications
  • Waldenstrom Macroglobulinemia / drug therapy*
  • Waldenstrom Macroglobulinemia / pathology

Substances

  • Piperidines
  • Pyrazoles
  • Pyrimidines
  • ibrutinib
  • Adenine